Spiriva and DYSPNOEA

20,984 reports of this reaction

7.9% of all Spiriva reports

#2 most reported adverse reaction

Overview

DYSPNOEA is the #2 most commonly reported adverse reaction for Spiriva, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.. There are 20,984 FDA adverse event reports linking Spiriva to DYSPNOEA. This represents approximately 7.9% of all 266,551 adverse event reports for this drug.

Patients taking Spiriva who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA20,984 of 266,551 reports

DYSPNOEA is moderately reported among Spiriva users, representing a notable but not dominant share of adverse events.

Other Side Effects of Spiriva

In addition to dyspnoea, the following adverse reactions have been reported for Spiriva:

Frequently Asked Questions

Does Spiriva cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 20,984 FDA reports for Spiriva. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with Spiriva?

DYSPNOEA accounts for approximately 7.9% of all adverse event reports for Spiriva, making it one of the most commonly reported side effect.

What should I do if I experience DYSPNOEA while taking Spiriva?

If you experience dyspnoea while taking Spiriva, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.